Pargyline and methyldopa may be useful alternatives to guanethidine for the individualized treatment of severe hypertension.
Answers are grounded in this paper and cite their sources.
May support individualized alternatives to guanethidine in severe hypertension; leaves open confirmation in prospective trials.
Greater individualization of treatment in severe hypertension may be possible as the number of available antihypertensive drugs increases.Two enzyme inhibitors, pargyline and methyldopa, appear in preliminary observations to be useful in treating severe hypertension. Situations in which either compound could be substituted for guanethidine are described.
No takes yet. Share an insight, caveat, or question.
Horwitz et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: